Amendment of import policy conditions for item under ITC(HS) Code 05119999 of Chapter 05 of ITC (HS), 2022, Schedule I (Import Policy).

## Policy Analysis Report: Amendment to Import Policy for Human Embryos (2022) **1. Executive Summary:** This report analyzes an amendment to the import policy conditions for item code ITCHS 05119999, concerning the import of human embryos. The amendment, issued on July 20, 2022, *prohibits* the import of human embryos, except for research purposes adhering to the guidelines of the Department of Health Research. This prohibition is further aligned with The Assisted Reproductive Technology Regulation Act, 2021, and The Surrogacy Regulation Act, 2021, indicating a move towards stricter regulation of human embryo imports in the context of assisted reproductive technologies and surrogacy. **2. Introduction:** The purpose of this report is to provide an informative analysis of the amendment to the import policy for human embryos, as detailed in the provided official notification dated July 20, 2022. This analysis is based solely on the information presented within the provided text. **3. Policy Overview:** * This analysis concerns an **amendment** to the existing "Foreign Trade Policy (FTP) 2015-2020," specifically impacting import policy conditions related to ITCHS code 05119999 under Chapter 05 of ITC HS, 2022, Schedule I Import Policy. * **Core Objective:** The primary objective of this amendment, as inferred from the text, is to regulate the import of human embryos, particularly concerning the context of assisted reproductive technologies and surrogacy. The amendment aims to align import regulations with domestic laws governing these practices. **4. Background and Rationale:** The amendment likely arises from a need to align import policies with newly enacted domestic legislation concerning assisted reproductive technologies and surrogacy, specifically The Assisted Reproductive Technology Regulation Act, 2021, and The Surrogacy Regulation Act, 2021. The original policy presumably allowed for broader import of human embryos, which the government now deems necessary to regulate more stringently in light of these Acts. The amendment seems designed to prevent the import of human embryos for purposes that would violate the principles and regulations outlined in the aforementioned Acts. **5. Key Provisions / Changes:** This is an amendment; therefore, the focus is on the change introduced: * **Specific Part of Original Policy Changed:** The amendment modifies the "Existing Policy Condition" related to ITCHS code 0511 99 99 ("Other: Other") concerning human embryo imports. The original policy stated that the import of Human Embryo was free for research purposes. * **New Rule/Provision:** The *revised* policy condition states: "Import of Human Embryo is Prohibited except for research purposes based on the guidelines of the Department of Health Research. Import of Human Embryo is Prohibited in accordance with The Assisted Reproductive Technology Regulation Act, 2021 and The Surrogacy Regulation Act, 2021." Effectively, human embryo imports are now *prohibited* except for research purposes conforming to stated conditions. * **Difference/Effect of Change:** The amendment significantly restricts the import of human embryos. Previously, import was "Free" (presumably with certain conditions) for research. Now, import is prohibited *except* for research adhering to the stated conditions. This change likely aims to prevent the import of human embryos for uses related to assisted reproductive technologies or surrogacy that do not comply with domestic regulations, thereby protecting ethical and legal standards in these areas. **6. Target Audience and Stakeholders:** The primary target audience and stakeholders are: * Entities involved in the import of biological materials, specifically human embryos. * Research institutions and scientists involved in research utilizing human embryos. * Clinics and practitioners involved in assisted reproductive technologies. * Individuals or organizations involved in surrogacy arrangements. * Relevant government agencies responsible for enforcing import regulations. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, is responsible for issuing and implementing this amendment. The Department of Health Research is referenced for setting guidelines related to research purposes. * **Timelines/Procedures:** The amendment is effective from July 20, 2022, the date of the notification. The text does not specify any explicit procedures, but importers will need to adhere to the new prohibition and any research institutions looking to import human embryos will likely need to demonstrate compliance with the guidelines issued by the Department of Health Research, and the Assisted Reproductive Technology Regulation Act, 2021 and the Surrogacy Regulation Act, 2021. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of this amendment is: * Stricter control over the import of human embryos. * Alignment of import policies with domestic laws governing assisted reproductive technologies and surrogacy. * Reduced risk of unethical or illegal uses of imported human embryos. * Ensuring that any imported human embryos are used only for ethically sound research purposes, under strict guidelines and regulations. * Increased scrutiny of import applications for human embryos. **9. Conclusion:** The amendment to the import policy for human embryos represents a significant shift towards stricter regulation. By prohibiting import except for specific research purposes aligned with national legislation on assisted reproductive technologies and surrogacy, the amendment aims to ensure ethical and legal compliance in the use of imported human embryos. This change will likely have a direct impact on research institutions, importers, and practitioners in the field of reproductive health.

Key Entities Referenced